Publicado oct 14, 2015



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar


Salomón Jakubowicz

##plugins.themes.bootstrap3.article.details##

Resumen

El medicamento metformina es ampliamente utilizado desde hace cincuenta años por diabéticos y pacientes con obesidad. Recientemente se ha descubierto que previene varios tipos de cáncer y disminuye la agresividad de algunos tumores.

Keywords

metfomin, cancer, diabetes, obesity, metformina, cáncer, diabetes, obesidad,

References
1. Andújar-Plata P, Pi-Sunyer X, Laferrère B. Metformin effects revisited. Diabetes Res Clin Pract. 2012;95(1):1-9.
2. Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009 Sep;32(9):1620-5.
3. Czyzyk A, Szczepanik Z. Diabetes mellitus and cancer. Eur J Intern Med. 2000 Oct;11(5):245-52.
4. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009 Dec;16(4):1103-23.
5. Martín-Castillo B, Vázquez-Martín A, Oliveras-Ferraros C, Menéndez JA. Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle. 2010 Mar 21;9(6):1057-64.
6. Duncan BB, Schmidt MI. Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research. Diabetes Care. 2009 Sep;32(9):1748-50.
7. Hardie DG. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett. 2008 Jan 9;582(1):81-9.
8. Jalving M, Gietema JA, Lefrandt JD, et al. Metformina: taking away the candy for cancer? Eur J Cancer. 2010 Sep;46(13):2369-80.
9. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009 Sep;52(9):1766-77.
10. Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010 Feb;33(2):322-6.
11. Chen TM, Lin CC, Huang PT, Wen CF. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation. J Gastroenterol Hepatol. 2011 May;26(5):858-65.
12. Lee MS, Hsu CC, Wahlqvist ML, Tsai HN, Chang YH, Huang YC. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer. 2011;11:20.
Cómo citar
Jakubowicz, S. (2015). ¿Puede la metformina prevenir el cáncer?. Universitas Medica, 56(4), 487–490. https://doi.org/10.11144/Javeriana.umed56-4.pmpc
Sección
Revisión de tema